You searched for "vision"

1774 results found

British Council for Prevention of Blindness has a new Chairman

BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.

Visual acuity outcomes in Coat’s disease by classification stage

This is a retrospective study of 160 consecutive patients with Coat’s disease under the Shields classification, with Snellen visual acuity (VA) pre and post treatment. Affected eyes were categorised based on the Shields classification: Stage 1: retinal telangiectasia onlyStage 2a:...

Intravitreal Ziv-Aflibercept: safety analysis

Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...

How does low-concentration atropine reduce progression of myopia?

This is a double-blind, randomised, placebo-controlled trial evaluating the effects of low-concentration atropine (0.05%, 0.025%, 0.01%) on ocular biometrics of myopic children. The aim is to determine what aspect of ocular biometrics low-concentration atropine influenced in reducing the progression of...

Efficacy and safety of novel PF brimonidine / timolol fixed-combination ophthalmic solution for OAG

This study is a multicentre, randomised, open-label, parallel-group clinical trial to evaluate the efficacy and safety of a newly developed preservative-free (PF) brimonidine / timolol fixed-combination (BTFC) ophthalmic solutions as compared with preservative-containing (PC) BTFC ophthalmic solution in adult patients...

Does pregnancy cause progression of keratoconus in previously cross-linked corneas?

This is a prospective study involving 24 eyes of 19 patients with stabilised or regressed keratoconus after a successful accelerated cross linking (A-CXL) treatment. Patients were recruited at a routine follow-up visit in the first month of their pregnancy. The...

Eye care practitioners urged to sign up for Love Your Lenses Week

Registration is now open for Love Your Lenses Week 2023, with this year’s campaign promising to ‘put contact lenses firmly in the public eye’.

Jessica Bartlett joins Glaukos as Territory Manager, North West England / Yorkshire

Glaukos Corporation is delighted to announce the appointment of Jessica Bartlett to the position of Territory Manager, Northwest, and Yorkshire.

Are illness perception or personality factors associated with follow-up appointment attendance in neuro-ophthalmology?

This was a prospective study which surveyed adults with appointments in either neuro-ophthalmology or the glaucoma service at a tertiary clinic. The aim of the study was to identify factors linked to attendance of follow-up appointments. Recruitment occurred over a...

Stent inject® W shelf life extended from 12 months to three years

Glaukos is delighted to announce that the expiry date for their innovative iStent inject® W device has been increased from 12 months to three years.

Conor Lavery promoted to Glaukos National Field Sales Manager, UK and Ireland

Glaukos is delighted to announce the promotion of Conor Lavery to National Field Sales Manager UK & Ireland, in his new role he will manage the Sales teams in these counties and provide support to Northern Europe management.

Print refresh for leading optical journal, Optometry Today

Optometry Today (OT) rolls out its first full print refresh since 2015, launching in the August/September edition.